Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The reason it is taking longer is because the fda requested the test plan. It’s not like rdgl can read their minds and have it done already before knowing that’s what they requested. So if it takes a few weeks to formulate the test plan fda is requesting then why wouldn’t fda expedite the review if that’s what they requested.
While time may be longer still doesn’t change where we were to where we are now. If I can personally go though the last 5 years of progress with the speed bumps they had along the way I can go a bit longer knowing what we have proven and what is on the horizon near term. We are good with financing and have investors lined up if need be but I am thinking great news coming before EOY.
I guess what I’m saying is if you believe the runway ends in a few months and that approval will take longer then you have a losing lotto ticket an you could sell it now to get out. ??
Haha similar thoughts we have
Well on our way to a dime again soon.
Today is my birthday so they owe me some great news! Lol just kidding but it is my birthday
If MK has nothing to report neither do you
“Another three weeks of cash/time runway gone without news. Offering remains dead in water. Understand MK has nothing to report”
Sorry guys early morning and I noticed the price range recently then read the company overview. Honestly didn’t go much further other then cancer and tumors. You can delete post
Very clean write up, I would agree with this projection being an extremely conservative number.
Well it’s been nearly two weeks already and if they were already working something as they say then I can’t imagine it taking much longer to submit to fda for review and get the test started
I spoke my good and great on the company
I spoke my concerns and bad on the company
What I need now as a share holder of 5 plus years and a significant share count is reassurance from the company on short term outlook and timeline with test plan, timeline with fda, and money on hand.
Reassure me on those three and I’m good again for awhile. This unknown guessing I’m not a fan of.
Disagree. The dr can give a conservative date of how long it will take to create such a document as he has been doing this over and over again. As far as the fda, even though they say they will expedite who really knows how fast that is.
Not sure if I remember them saying when they would give an update. Only thing is that they are supposedly ahead of what the fda requested and it’s in work. Have no clue when we are expected to hear something nor what the timeline could be to get it done. A lot of speculation on this board about timing but for the most part we have all been wrong because there has always been another step to slow us down unfortunately. Still confident but at a certain point the Dr needs to be very clear about where they are at and what the near term expectations are in a timeline stand point. I’d rather know things are moving then not. If they put something out saying a month until we submit for final meeting before submission I’d be ok with that because at least there is a target as all targets can possibly move at least we see each step along the way. Being this close and yet so far in the sense of not knowing the timeline doesn’t sit well after so long
We need a timeline
All I can say is if things get completely reset with FDA due to the polymer change then we are all screwed. I hope that is not the case.
We are at $0.08ish once final test and meeting dates set we start the below SP action IMO
Leading up to IDE submission $0.25-$0.34
Leading up to approval $0.50-$1.50
On approval $0.50-$2.25
Phase 1 $0.70-$1.20
Phase 2 $2.50-$$$explosion unknown$$$
Buy out potential $1.5B-$3.5B
No matter how you slice it and dice it. Fact is we are on our last test expedited at that for the hand walking fda approval of ide to go straight into humans at Mayo Clinic
Read second paragraph from September 20, 2021 Pr
https://feeds.issuerdirect.com/news-release.html?newsid=5509154940334738
But you just said a buyout a few post ago on ide approval. How can you get back in from exiting your liquidity event if you miss the buyout. And there are no shares to buy anymore because someone bought them out. Flipping an flopping
That’s low but very conservative. I’d say minimum 1 to 1.5 bill
Yeah man the market has been a disappointment
Perhaps you entire thought changes since this test plan is not through Mayo Clinic it is through John Hopkins with a rabbit.
O looky there we already closed the gap.
Let me know what you find out since I know what it is and apparently you do not
Probably gap up to 0.085/0.086 then slowly trickle down hopefully sit at no lower then 0.075 until update on dates for test
Not concerned as it’s a mute share price anyway. Once test is scheduled and results come back this thing goes parabolic
Twitter comment and answer!
Comment
“Great to hear, how long will this test take? Are there already candidates at John’s Hopkins awaiting the procedure?”
Answer
Everything is in process. We are working on an accelerated timeline with no fixed dates at this moment.
Thank you for the question.
Just want to know how much time
New tweet. Another test but will be very quick as it is with rabbits and I’m
Sure there are plenty of test subjects available to get this started asap. Also it’s with John’s Hopkins which is huge and sounds like FDA is running out of things to push the approval which is also great.
What are you even smoking?
Think we are going to have a slight shake down day.
Even if another test is required I’m locked and holding
Very surprised they haven’t tweeted anything. Notorious for tweeting in bulk
Cancer stocks are warming up FAST
Rdgl bullets
- it works
- better then seeds
- better then beam radiation
- Approved for animals
- pet insurance covers it
- Awaiting fda approval
- low OS
- high accumulation in float
- moonshot program potential
- no toxic debt
- better then ISR
- hand walk with FDA for gaining approval
- results known in weeks to a few months after procedures
- half life is quicker then all others on market
- patents are increasing
- international interests and patents completed and or on the horizon
- price is 0.095 with potential to pop over 1.50 very quickly
- so much more …. Moose! And others plus horses cats, etc.
- Mayo Clinic
- John Hopkins
- Biden needs a win and cancers ie RDGL could be that win. Just approve them get to humans show it works and let it spread across the globe
$$$$ IMHO
Pet insurance covers the procedure and soon heath insurances will for humans!
I’m leaning towards great news. Usually the Twitter feed is bombarded with tweets to keep the share price propped up. Because of this silence I feel they may be gathering a PR for Monday or Tuesday. I sure hope so
Not to bad today, hard call on where we go from here but I’d like to see us pass 0.35, get through that resistance level on really good news. But we shall see
Tap 0.0926 before close then pop right at close. Get in before the weekend
I’m going to toot my horn for a second toot toot
Good day